A
$ Value
$0
Shares
37,248
Price
$0
Filed
Jan 16
Insider
Name
RABINOWITZ DANIEL
Title
SEC. AND CHIEF LEGAL OFFICER
CIK
0001857843
Roles
Officer
Transaction Details
Transaction Date
2026-01-14
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
245,849
Footnotes
On January 27, 2023, the Reporting Person was granted a performance-based Restricted Stock Unit (RSU) award which vests in tranches upon the achievement of milestones relating to a combination of the passage of time and certain business performance criteria. On January 14, 2026, the performance threshold with respect to one milestone under the RSUs was certified, resulting in the vesting of 37,248 shares of Common Stock.
Filing Info
RABINOWITZ DANIEL's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | NTRA | ▼ | $60K |
| 2026-04-01 | NTRA | ▼ | $359K |
| 2026-04-01 | NTRA | ▼ | $652K |
| 2026-04-01 | NTRA | ▼ | $245K |
| 2026-04-01 | NTRA | ▼ | $391K |
| 2026-03-10 | NTRA | ▼ | $356K |
| 2026-03-09 | NTRA | A | — |
| 2026-03-06 | NTRA | M | $110K |
| 2026-03-06 | NTRA | ▼ | $77K |
| 2026-03-06 | NTRA | ▼ | $565K |
Other Insiders at NTRA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| BOTHA ROELOF | — | — | 2026-01-30 |
| ROSENMAN HERM | — | — | 2026-01-30 |
| Williams Brinkley Ruth | — | — | 2026-01-30 |
|
Rabinowitz Matthew
EXECUTIVE CHAIRMAN
|
— | $38.3M | 2026-04-06 |
| Sheena Jonathan | — | $2.4M | 2026-04-17 |
| Baynes Roy D. | — | — | 2026-01-30 |
|
Brophy Michael Burkes
CHIEF FINANCIAL OFFICER
|
— | $2.9M | 2026-03-10 |
| Marcus Gail Boxer | — | — | 2026-01-30 |
|
Chapman Steven Leonard
CEO AND PRESIDENT
|
— | $24.1M | 2026-03-10 |
| Bertagnolli Monica | — | — | 2026-01-30 |
| Chapman Rowan E | — | $23K | 2026-03-13 |
|
RABINOWITZ DANIEL
SEC. AND CHIEF LEGAL OFFICER
|
— | $4.5M | 2026-04-01 |
|
Moshkevich Solomon
PRESIDENT, CLINICALDIAGNOSTICS
|
— | $3.0M | 2026-04-01 |
|
Fesko John
PRESIDENT, CHIEF BUS. OFFICER
|
— | $1.4M | 2026-03-10 |